Piperacillin-tazobactam and Temocillin as Carbapenem-alternatives for the Treatment of Severe Infections Due to Extended-spectrum Beta-lactamase-Producing Gram-negative Enterobacteriaceae in the Intensive Care Unit

Clinical trial NCT05565222 · UNKNOWN

Trial details

NCT number: NCT05565222
Sponsor: Assistance Publique - Hôpitaux de Paris
Status: UNKNOWN
Phase: Phase 3
Study type: INTERVENTIONAL

Sepsis Septic Shock

Start date: 2023-03-11
Primary completion: 2026-04-01
Enrollment: 600

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.